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Abstract
Background: In 2007 WHO issued a guideline to improve the diagnosis of smear-negative and extrapulmonary tuberculosis
(EPTB) in HIV-positive patients. This guideline relies heavily on the acceptance of HIV-testing and availability of chest X-rays.
Methods and Findings: Cohort study of TB suspects in four tuberculosis (TB) clinics in Phnom Penh, Cambodia. We assessed
the operational performance of the guideline, the incremental yield of investigations, and the diagnostic accuracy for
smear-negative tuberculosis in HIV-positive patients using culture positivity as reference standard. 1,147 (68.9%) of 1,665 TB
suspects presented with unknown HIV status, 1,124 (98.0%) agreed to be tested, 79 (7.0%) were HIV-positive. Compliance
with the guideline for chest X-rays and sputum culture requests was 97.1% and 98.3% respectively. Only 35 of 79 HIV-
positive patients (44.3%) with a chest X-ray suggestive of TB started TB treatment within 10 days. 105 of 442 HIV-positive TB
suspects started TB treatment (56.2% smear-negative pulmonary TB (PTB), 28.6% smear-positive PTB, 15.2% EPTB). The
median time to TB treatment initiation was 5 days (IQR: 2–13 days), ranging from 2 days (IQR: 1–11.5 days) for EPTB, over 2.5
days (IQR: 1–4 days) for smear-positive PTB to 9 days (IQR: 3–17 days) for smear-negative PTB. Among the 34 smear-negative
TB patients with a confirmed diagnosis, the incremental yield of chest X-ray, clinical suspicion or abdominal ultrasound, and
culture was 41.2%, 17.6% and 41.2% respectively. The sensitivity and specificity of the algorithm to diagnose smear-negative
TB in HIV-positive TB suspects was 58.8% (95%CI: 42.2%–73.6%) and 79.4% (95%CI: 74.8%–82.4%) respectively.
Conclusions: Pending point-of-care rapid diagnostic tests for TB disease, diagnostic algorithms are needed. The diagnostic
accuracy of the 2007 WHO guideline to diagnose smear-negative TB is acceptable. There is, however, reluctance to comply
with the guideline in terms of immediate treatment initiation.
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Introduction
The World Health Organization (WHO) has classified Cambo-
dia as one of the 22 high burden countries with tuberculosis (TB)
in the world. [1] In 2007 the TB incidence rate of all forms was
estimated at 495/100,000 inhabitants per year, with estimated
death rates of 77/100,000 and 13/100,000 per year among HIV-
positive and HIV-negative populations respectively. [2] In 2006
the reported HIV prevalence fell to an estimated 0.9% among the
adult population (15–49 years) from 1.9% in 2003. [3] In 2007, the
HIV-prevalence among TB patients was estimated to be 7.8%. [4]
Rates of smear-negative pulmonary and extrapulmonary TB
have been rising in countries with HIV epidemics. [5,6] HIV-
positive TB patients experience higher mortality rates than HIV-
negative TB patients, especially those with smear-negative
pulmonary or extrapulmonary tuberculosis. [7–10] Delayed TB
diagnosis may be an important contributor to this excess mortality
in HIV-infected persons. [7,11–13]
Diagnosis of smear-negative and extrapulmonary tuberculosis is
challenging and hampered by the lack of simple, rapid and
accurate diagnostic tests. [14] Autopsy studies have found
disseminated TB in 40–54% of HIV-infected people in HIV
prevalent countries, many of whom were undiagnosed prior to
death. [15–18]
In the absence of a rapid diagnostic test several diagnostic
algorithms have been recommended. [19] In 2007, a WHO
international expert committee issued a new guideline to improve
the diagnosis of TB in HIV-positive patients in HIV prevalent
settings. [20] The new guideline was in the first place designed to
reduce the delay in diagnosing TB in HIV-positive patients and in
the second place to include a more sensitive tool than direct
microscopy. For that reason new investigation means were added
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(culture), and existing tools were allowed to be carried out earlier
in the diagnostic pathway (X-ray), and this after all suspects were
categorized into two groups: HIV-positive and HIV-negative
patients. It was recognized by the expert team that this strategy
would increase the sensitivity and compromise the specificity, but
this was considered the necessary price to reduce mortality in the
HIV-positive TB patients. This new guideline is based on expert
opinion and relies heavily on the acceptance of an HIV-test and
the availability of chest X-rays. In this cohort study we assessed the
operational performance (acceptability, feasibility and compliance)
of the WHO 2007 guideline in ambulatory TB suspects in four
Cambodian TB clinics with a variable proportion of HIV-positive
patients and we evaluated its performance to diagnose smear-
negative TB in HIV-positive patients.
Methods
Settings
The study was conducted in four sites in Phnom Penh,
Cambodia: the TB clinic of the National Center for Tuberculosis
and Leprosy Control (CENAT) and the Pochentong District
Hospital; the TB clinic of the Sihanouk Hospital Centre of Hope
(SHCH), a NGO referral hospital, and the TB clinic of Chey
Chumneas (CCN) Provincial Hospital. The latter two health
structures have a higher proportion of HIV-positive patients as
they are known as HIV treatment centers providing antiretroviral
treatment.
Inclusion and exclusion criteria
Adult patients ($18 years old) were enrolled between July 2008
and July 2009. Based on the clinical characteristics suggestive of
TB as described in the WHO diagnostic algorithm [20], TB
suspects were classified in two groups: 1) cough for more than 2
weeks referred to as the ‘‘cough.2 weeks’’ group, or 2) absence of
cough more than 2 weeks but any of the following symptoms:
weight loss with night sweats or feeling feverish with T.37.5u,
breathlessness due to pleural effusion or pericarditis, enlarged
(.2 cm) glands in neck or armpit, chronic headache or altered
mental state, or an abnormal chest radiograph, hereafter referred
to as ‘‘no cough or cough ,2 weeks’’ (Figure 1).
Patients with danger signs (defined by the WHO guideline as
respiratory rate .30/minute, fever .39uC, pulse rate .120/
minute and unable to walk unaided) should follow a different
algorithm and were not the scope of this study, and thus excluded.
Flow of patients
All TB suspects with unknown HIV status were counselled and
tested for HIV on the first day together with collection of a sputum
sample for direct microscopic examination. Because of the low
HIV prevalence in Cambodia, patients with a documented
negative HIV test result less than a year old were considered
HIV-negative (to avoid repeated HIV testing). For HIV-negative
patients the national TB guideline based on the WHO 2003
guideline [21] was followed, for HIV-positive patients or patients
with strong clinical suspicion of HIV the WHO 2007 guideline
(Figure 2). [20] In the latter group a patient with one smear
examination positive for acid-fast bacilli (AFB) was defined as
smear-positive pulmonary tuberculosis. If the sputum was found to
be smear-negative (at least 2 smears negative), a chest radiograph
was requested. When it was suggestive of tuberculosis or when the
clinical assessment was suggestive of TB (lymphadenitis or
abnormal abdominal ultrasound) the patient had to be treated as
smear-negative pulmonary or extrapulmonary tuberculosis with-
out an antibiotic trial.
Abdominal ultrasound was performed in one setting (SHCH),
though not systematically.
All TB patients were followed up until they finished TB
treatment, unless they were transferred out, lost to follow-up
(LTFU) or died.
Laboratory methods
HIV testing was done on the day of presentation following the
national HIV testing protocol. Sputum examinations were done
on the day of presentation (on the spot) and on the next morning
sample (morning and on the spot). SHCH and CENAT used
auramine stain (positive smears confirmed by Ziehl-Neelsen), while
Figure 1. Inclusion criteria and screening questions for TB suspects*.
doi:10.1371/journal.pone.0018502.g001
Diagnosis of TB in HIV-Positive Patients
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Figure 2. WHO algorithm for the diagnosis of tuberculosis in ambulatory HIV-positive patients.
doi:10.1371/journal.pone.0018502.g002
Diagnosis of TB in HIV-Positive Patients
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the other centres used Ziehl-Neelsen (ZN). Mycobacterial culture
of sputum was done for all HIV-positive TB suspects. The second
sputum (morning) was stained with ZN at the site and
subsequently sent for TB culture at CENAT. Solid media cultures
(Ogawa) were used. In SHCH the third on spot specimen of HIV-
positive TB suspects was also cultured using Lo¨wenstein-Jensen
medium.
Imaging studies
For each chest X-ray a standardized form was filled out by the
treating physician. The findings were summarized as normal,
abnormal suggestive of TB, abnormal not suggestive of TB, and
unknown or not available. All chest X-rays were later reviewed by
2 expert radiologists who were blinded to the patient’ clinical
condition. The inter-observer agreement was assessed by estimat-
ing pairwise kappa statistics. The values of kappa were classified
according to the method described by Landis [22] for the
distinction between normal and abnormal in all X-rays, and the
distinction between TB and non-TB in X-rays defined as
abnormal by both readers.
Data management and analysis
The doctors and nurses of the study sites were trained in the use
of the guideline and specific data-collection tools. Data were
entered centrally in a research database (Microsoft Access 2003).
Compliance with the diagnostic algorithm and with the
treatment recommendation was used to assess the operational
performance of the guideline. Compliance with the treatment part
of the WHO guideline was pre-specified in the protocol as ‘‘having
started TB treatment within 10 days of presentation’’ (taking into
account delays in results and appointments) in patients with two
negative sputum smears and a chest radiograph suggestive of TB
or clinical signs suggestive of TB.
The incremental yield of the different investigations was defined
as the proportion of patients additionally diagnosed by X-ray if
smear-negative, by clinical suspicion or abdominal ultrasound in
smear-negatives without an X-ray suggestive of TB, and ultimately
by culture if all of the above were negative. We assessed the
incremental yield among HIV-positive patients treated for TB
(decision by a clinician to treat with a full course of anti-TB
chemotherapy with or without confirmation), and among
confirmed smear-negative TB patients (using culture positivity at
CENAT or SHCH for Mycobacterium tuberculosis as reference
standard).
Time to TB treatment initiation was calculated for all patients
treated for TB as the time between first presentation and start of
TB treatment at the clinic. The outcomes of all TB patients were
classified following standard WHO definitions [23] and retrieved
using the national TB registers at CENAT.
The diagnostic performance of the WHO 2007 guideline to
diagnose smear-negative TB was assessed by excluding smear
positive PTB cases from the analysis. We calculated the sensitivity
and specificity, and positive and negative predictive value of the
WHO 2007 diagnostic algorithm using culture positivity at
CENAT or SHCH for Mycobacterium tuberculosis as reference
standard. Patients without X-ray results or culture results were
excluded from this analysis. Confidence intervals around
sensitivity and specificity were calculated using the Wilson’s
method. Appropriateness of pooling the observed sensitivities and
specificities over different sites was tested using logistic regression
models.
All statistical analyses were performed using Stata software,
version 11.1. (Stata Corporation, College Station, TX, USA).
Ethics statement
The study protocol, data collection forms and informed consent
procedure were approved by the Research Ethics Review
Committee of WHO, by the Institutional Review Board of the
Institute of Tropical Medicine in Antwerp, by the Ethics
Committee University Hospital Antwerp, and by the National
Ethics Committee in Cambodia. Only patients who gave written
informed consent were enrolled in the study.
Role of the funding source
The study was funded by WHO (WHO registry file number T9-
181-298), with additional funding from the Belgian Development
cooperation (DGDC) through a framework agreement with the
Institute of Tropical Medicine in Antwerp (institutional strength-
ening project 920800) and the Belgian National Association
against Tuberculosis (BNBTTB).
The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Results
A total of 1,677 TB suspects were enrolled. Of these patients, 12
were excluded from further analysis: 10 patients were below 18
years at presentation, and 2 patients had already started TB
treatment at presentation.
Patient characteristics
1,665 patients were included at the four sites (Table 1). The
median age of patients enrolled was 37 years (range, 18–86), and
844 (50.7%) were male. The majority of TB suspects presented
with ‘‘cough more than two weeks’’ (86.5%), ranging from 72.4%
at Chey Chumneas (CCN) Provincial Hospital to 99.6% at
Pochentong District Hospital. TB suspects with ‘‘no cough or
cough ,2 weeks’’ mainly presented at SHCH and CCN
Provincial Hospital. The main entry points for TB suspects with
‘‘no cough or cough ,2 weeks’’ were weight loss (80.9%) and/or
chronic headache/altered mental state (48.4%). 442 (26.5%) TB
suspects were HIV positive. The HIV prevalence varied greatly
between the sites ranging from 2.1% at CENAT to 46.9% at CCN
and 55.4% at SHCH.
Among the 442 HIV-positive TB suspects 312 (70.6%)
presented as suspects with ‘‘cough . 2 weeks’’ and 130 (29.4%)
with ‘‘no cough or cough , 2 weeks’’.
Operational performance of the WHO algorithm
Diagnostic pathway (Figure 3). 518 TB suspects (31.1%)
presented with known HIV status: 363 patients with a documented
HIV positive test and 155 patients with a documented negative test
of less than a year old. HIV testing was performed in 1124 TB
suspects (98.0%) with unknown HIV status, in 6 patients a test was
not asked and 17 patients refused to be tested. 79 (7.0%) of the TB
suspects with unknown HIV status were HIV-positive. Sputum
microscopy was performed in all but 34 TB suspects (98.0%). A
chest X-ray was requested for 400 out of the 412 HIV-positive
smear-negative TB suspects (97.1%). Samples for sputum culture
were requested for 405 HIV-positive smear-negative TB suspects.
13 culture results were unavailable.
Treatment recommendation (Figure 3). The chest X-ray
result was considered by the treating physician suggestive of TB in
79 smear-negative TB suspects (62 suspects with ‘‘cough . 2
weeks’’ and 17 with ‘‘no cough or cough ,2 weeks’’). Only 35
(44.3%) were started on TB treatment within 10 days, 15 (19.0%)
were started on TB treatment after 10 days, and 29 (36.7%) were
not started on TB treatment. The sputum culture was positive in
Diagnosis of TB in HIV-Positive Patients
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34 of the 392 smear-negative TB suspects for which results were
available. 17 patients (50%) were already on treatment when the
result came, 7 (20.6%) were started on treatment thanks to the
culture result and 10 (29.4%) were not started on treatment despite
the culture results, because the patients had died or were lost to
follow-up by the time the result was available.
Incremental yield (Table 2). Among the 105 patients who
started TB treatment 30 were detected because of a positive smear,
an additional 53 were treated because of a suggestive chest X-ray,
18 (17.1%) more because of clinical presentation or abdominal
ultrasound suggestive of TB and only 4 (3.8%) because of positive
culture. Among the 34 confirmed smear-negative TB patients,
about forty percent (14/34) were diagnosed by chest X-ray, about
20% more by abdominal ultrasound or clinical suspicion and
finally also forty percent by culture only (14/34).
The median time to detection among these 14 additional TB
patients was 66.5 days (IQR: 56–70 days). As a result of the long
detection time, only 4 of those 14 patients started TB treatment
after a median time of 110 days (range: 73–147 days), 2 patients
had died and 8 were LTFU.
Diagnostic accuracy of the WHO 2007 algorithm for
smear-negative TB
Considering only the smear-negative cohort of TB suspects
(n = 374), the diagnostic algorithm had a sensitivity of 58.8%
(95%CI: 42.2%–73.6%) and a specificity of 79.4% (95%CI:
74.8%–82.4%) using culture positivity as reference standard.
(Table 3, Figure 4) There was no statistically significant
heterogeneity of the observed sensitivities and specificities of the
diagnostic algorithm between the different sites.
If patients with an abnormal X-ray (irrespective whether
suggestive of TB or otherwise) would have been started on TB
treatment, the sensitivity would have increased to 64.7% (95%CI:
47.9%–78.5%) while the specificity would have decreased to
72.9% (95%CI: 68.0%–77.4) (data not shown).
Inter-observer agreement for chest X-rays
For the assessment of agreement between the readers, 349 chest
X-ray reports were available. The inter-observer agreement was
good for distinction between normal and abnormal X-rays (k
ranging from 0.62 to 0.72), but only fair for distinction between
TB and non-TB (k ranging from 0.28 to 0.42) (data not shown).
5 of the 79 chest X-rays suggestive of TB by the site physician
were not available for interpretation by the 2 expert radiologists.
Of the remaining 74 chest X-rays that were reported as suggestive
of TB by the treating physician, only 48 (64.9%) and 42 (56.8%)
were classified as suggestive of TB by the expert radiologists.
TB categories and treatment outcomes
TB treatment was started in 105 HIV-positive patients
(Figure 5). Fifty-nine patients (56.2%) were categorized as
smear-negative PTB, 16 (15.2%) as EPTB and 30 patients
(28.6%) as smear-positive PTB. The patients with presumed
EPTB were diagnosed by chest X-ray (miliary TB), abdominal
ultrasound (enlarged abdominal lymph nodes) and by clinical
examination (TB adenitis) resulting in short treatment delays.
The median time to TB treatment initiation was 5 days (IQR:
2–13 days), ranging from 2 days (IQR: 1–11.5 days) for EPTB,
over 2.5 days (IQR: 1–4 days) for smear-positive PTB to 9 days
(IQR: 3–17 days) for smear-negative PTB.
Seventy five patients (71.4%) completed treatment or were
cured, 26 (24.8%) defaulted or were LTFU, 3 (2.8%) died, and 1
(1.0%) patient was categorized as treatment failure.
Discussion
Our study evaluated the operational performance of the WHO
2007 guideline for the diagnosis of TB in patients considered as
TB suspects in an HIV-prevalent setting. The WHO algorithm
needed validation in low-resource settings that are meant to
implement the guidelines. This brings about methodological
difficulties as it is problematic to create a research environment
in these circumstances allowing for a methodologically correct
evaluation of diagnostic accuracy of the algorithm.
Our research indicates that the acceptance rate for HIV testing
by TB suspects is high (98.0%) compared to other settings [24],
and compliance with the diagnostic flowchart by health staff was
acceptable. Although we did not compare the treatment delay with
historical data from the same setting, we think the delay is reduced
when comparing with data from literature on older algorithms.
[25] Taking into account that HIV-positive smear-negative TB
patients frequently do not receive a diagnosis for several months
because of delays due to additional diagnostic testing or antibiotic
treatment trials [26], the observed treatment delay of 5 days seems
reasonable. The treatment delay would have been further reduced
if compliance with the guideline in terms of faster treatment
initiation were better. Only about half of patients with a smear-
negative result who had a chest X-ray suggestive of TB were
Table 1. Characteristics and entry points of analyzed TB suspects.
TB suspects Entry-point HIV+ TB suspects
Cough . 2 weeks
No cough or cough ,2
weeks*
Total: n (%) 1665 (100.0) 1440 (86.5) 225 (13.5) 442 (26.5)
Age: years, median (range) 37 (18–86) 38 (18–86) 36 (18–73) 35 (18–69)
Male sex: n (%) 844 (50.7) 760 (52.8) 84 (37.3) 190 (43.0)
Location: n (%)
Sihanouk Hospital Centre of Hope 478 (28.7) 361 (75.5) 117 (24.5) 265 (55.4)
National Center for Tuberculosis and Leprosy Control 615 (36.9) 598 (97.2) 17 (2.8) 13 (2.1)
Chey Chumneas Provincial Hospital 326 (19.6) 236 (72.4) 90 (27.6) 153 (46.9)
Pochentong District Hospital 246 (14.8) 245 (99.6) 1 (0.4) 11 (4.5)
*Patients with no cough or cough ,2 weeks had other inclusion criteria.
doi:10.1371/journal.pone.0018502.t001
Diagnosis of TB in HIV-Positive Patients
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started on TB treatment without further delay. This contrasts with
the readiness of the clinicians to start empirical treatment for
presumed EPTB. Abdominal ultrasound identified 21% of the
confirmed TB diagnosis in the setting where ultrasound was
available, confirming the usefulness of abdominal ultrasound as a
diagnostic test for TB in HIV-positive patients. [27]
Our research indicates that the sensitivity of the 2007 WHO
guideline to diagnose smear-negative TB is acceptable: 58.8%
(95%CI: 42.2%–73.6%) of patients with confirmed TB were
identified by the diagnostic algorithm for smear-negative TB
suspects. Although somehow disappointing, this represents a
significant increase in early diagnosis compared to the previous
Figure 3. Operational performance of the WHO 2007 algorithm for the diagnosis of tuberculosis in ambulatory HIV-positive
patients (diagnostic pathway and treatment recommendation).
doi:10.1371/journal.pone.0018502.g003
Diagnosis of TB in HIV-Positive Patients
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guidelines and would lead to faster treatment in a significant
proportion of patients if guidelines were implemented as
recommended.
Sputum culture resulted in an additional yield of TB diagnoses
but this was offset by the delay inherent to solid culture methods
and the logistic constraints to trace patients post-hoc. About 70%
of the TB patients identified additionally by culture alone had died
or were LTFU when the results finally were available. Considering
the poor prognosis of untreated smear-negative TB in HIV-
positive patients we can assume that the LTFU patients have died,
which would result in a ‘corrected’ mortality of about 10%. Liquid
culture, as recommended by WHO [28] for high burden TB
countries, would help to shorten the detection time and probably
the mortality, but was not available in Cambodia at the time of the
study. Regular transport of samples and results to and from the
central laboratory are additional operational/logistical challenges
for both methods.
We observed a good agreement for distinguishing normal from
abnormal X-rays in all X-rays, but only a fair agreement for
distinction between TB and non-TB. Chest X-rays are an
important component of the algorithm, and adequate training
should receive proper attention. But taking into account the
difficulties in interpreting X-ray reading in HIV-positive patients
[29,30], the algorithm could be further simplified by commencing
TB treatment in any HIV positive patient with an abnormal X-
ray. This would increase the sensitivity of the algorithm in HIV-
positive TB suspects to 64.7% (plus 5.9%) but at a cost of a
decreased specificity of 72.9% (minus 6.5%).
The diagnostic means in this setting did not allow for a gold
standard definition of EPTB, which is a weakness of the study.
Moreover, our study is not assessing the sensitivity of the screening
questions to define a TB suspect. As such, the diagnostic
performance of the overall algorithm (both screening and
diagnostic) was not assessed. Sputum smear microscopy identified
a few smear-positive pulmonary tuberculosis cases among patients
who did not present with cough . 2 weeks. If we would have used
a more sensitive screening approach for PTB with a combination
of symptoms as entry point for PTB (any cough, any fever or night
sweats, or weight loss [31–34] without specifying the duration of
cough as Cain et al. [35] suggest, these patients would likely have
ended up in the PTB track. In our study the sensitivity of the
guideline to diagnose TB in smear-negative TB suspects with other
inclusion criteria than cough .2weeks is low: only 27.3% of
patients with positive sputum culture were detected by X-ray,
clinical suspicion or abdominal ultrasound. This further under-
scores the need to either revise the screening questions for PTB
and include cough of any duration, or to do sputum cultures in al
TB suspects, not only the ones coughing for more than 2 weeks.
Our study has some other limitations: we used solid culture as
reference standard for detecting pulmonary and extrapulmonary
TB. Culturing multiple specimens on liquid media would have
detected more confirmed TB cases [36,37], and could affect the
Table 2. Incremental yield of different examinations in HIV-positive patients started on TB treatment and in patients with
confirmed TB (reference standard: positive sputum culture).
All patients who started TB
treatment (n=105)
Smear-negative TB suspects with confirmed TB
diagnosis (n =34)
Positive smear
(at least 1 positive sputum smear)
30 (28.6%) NA
Chest X-ray suggestive of TB +53 (50.5%)* +14 (41.2%)
Clinical assessment suggestive of TB
(clinical suspicion or abdominal ultrasound)
+18 (17.1%) +6 (17.6%)
Positive culture +4 (3.8%) +14 (41.2%)"
*3 patients with an X-ray suggestive of TB but not started on TB treatment were started later because of a positive culture. 1 patient with an X-ray suggestive of TB but
not started on TB treatment and a positive culture was LTFU.
"Of the 14 patients diagnosed by sputum culture only, only 4 were started on TB treatment.
doi:10.1371/journal.pone.0018502.t002
Table 3. Diagnostic performance of the WHO 2007 algorithm in the smear-negative cohort of TB suspects, depending on inclusion
criteria (reference: positive sputum culture).
HIV+TB suspects* n (%) Cough . 2 weeks n (%)
No cough or cough ,2 weeks"
n (%)
Total, n (%) 374 (100.0) 258 (69.0) 116 (31.0)
Nr of confirmed TB cases (1 culture +) 34 23 11
Sensitivity, % (95% CI) 58.8 (42.2–73.6) 73.9 (53.5–87.5) 27.3 (9.7–56.6)
Specificity, % (95% CI) 79.4 (74.8–82.4) 78.7(73.1–82.5) 81.0 (72.4–87.3)
PPV, % (95% CI) 22.2 (14.9–31.8) 25.4 (16.5–36.9) 13.0 (4.5–32.1)
NPV, % (95% CI) 95.1 (91.9–97.0) 96.9 (93.3–98.6) 91.4 (83.9–95.6)
CI: Confidence interval; PPV: Positive predictive value; NPV: Negative predictive value
*Patients without X-ray results or culture results were excluded from this analysis.
"Patients with no cough or cough ,2 weeks had other inclusion criteria.
doi:10.1371/journal.pone.0018502.t003
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Figure 5. Distribution of TB categories among HIV-positive patients started on TB treatment.
doi:10.1371/journal.pone.0018502.g005
Figure 4. Diagnostic performance of the WHO guideline in the smear-negative cohort of TB suspects (reference: positive sputum
culture).
doi:10.1371/journal.pone.0018502.g004
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sensitivity and specificity of the diagnostic algorithm among HIV-
positive TB suspects.
The guidelines are meant for settings where the HIV prevalence
exceeds 1% in the general population or 5% among the TB cases.
In this study, 26.5% of the TB suspects were HIV-positive.
However the HIV prevalence varied greatly across sites: from
2.7% at CENAT to 55.4% at SHCH. This highlights the need to
identify within low HIV-prevalent countries the settings where the
guideline should be implemented.
The heterogeneity among the sites might also have contributed
to differences in delay of presentation of TB suspects at the study
sites. Nevertheless we did not find a statistically significant
difference in the diagnostic performance of the diagnostic
algorithm between the study sites. However, due to the small
number of confirmed TB cases (n = 34) the study lacks power to
examine this interaction.
Our study provides evidence that the application of the WHO
guideline, based on expert opinion, is feasible in the field.
However, several barriers for better patient outcomes exist: solid
culture needs to be replaced by liquid culture, sensitivity in smear-
negative TB is still relatively low and more sensitive rapid
diagnostic tests are needed such as the Xpert MTB/RIF assay.
[38]
Additional qualitative research among health care workers
could be useful to understand the hesitance to start patients on TB
treatment. Endorsement of the results by WHO and national TB
programs is important in order to remove perceived barriers to
implementation by practitioners in the field. [39]
Conclusions
Whilst awaiting easy point-of-care rapid diagnostic tests for TB
disease, diagnostic algorithms have a role to play. The diagnostic
accuracy of the 2007 WHO guideline to diagnose smear-negative
TB is acceptable. HIV-testing in all TB suspects is acceptable to
the patient and reduces delay in treatment if the recommendations
are implemented. There is however reluctance to comply with the
guideline in terms of immediate treatment initiation.
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